Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
The dividend growth powerhouse is turning the corner.
2 No-Brainer Warren Buffett Stocks to Buy Right Now
One of these stocks is a clear value; the other is a growth monster.
Wall Street Thinks Nvidia Stock Can Rise 30% in a Year. Time to Buy?
Nvidia’s GPUs are still in high demand.
Got $1,000? Here’s Your Ticket to Blockbuster Monthly Dividend Income.
This REIT is a smash hit for those seeking passive income.
Should You Buy the Only Vanguard Sector ETF That’s Down in the Past Month?
Investing in the energy sector is a great way to boost your passive income stream.
3 Things You Need to Know if You Buy Iovance Biotherapeutics Today
There’s plenty of upside with this stock, but it might take a while to realize.
2 Stocks Down 78% and 88% That Wall Street Is Overlooking — but I’m Not
These are two stocks that many investors aren’t paying much attention to. Here’s why they should.
Warren Buffett Has Nearly 50% of Berkshire Hathaway’s Investable Portfolio in 1 Incredibly Safe Bet
The Berkshire Hathaway CEO has added hundreds of billions to this position during the last few years.
Here’s Why Berkshire Hathaway Is Cheaper Than You Think at $1 Trillion
The conglomerate just reached a key valuation milestone and a major insider is selling shares.
2 Reasons to Buy Supermicro Stock Hand Over Fist — and 1 Reason to Stay Away
There’s one big fly in the ointment for this former high-flying stock.
Prediction: Amazon Will NOT Become the Market’s Next Dividend Stock, and This Is Why
The company has bucked a growing trend of returning cash to shareholders.
1 Top Cryptocurrency to Buy Before It Soars 22,000%, According to This Billionaire
Michael Saylor predicts that Bitcoin is far from reaching its full potential.
3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a Decade
Now could be a great time to scoop up three stocks trading way below their previous peaks.
Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?
Can the “dogs of the Dow” strategy work on the longer list of Nasdaq stocks?
Abbott Laboratories’ Best Segment Just Got Even Better: Is the Stock a Buy?
The company continues to flex its innovative muscles.
Forget Walmart: The Biggest Retail Stock Split of the Year Has Arrived
This high-growth specialty retailer — up 12,600% since its IPO — is primed for only its second stock split in 31 years as a public company.